Your browser doesn't support javascript.
loading
Characterization of disease-propagating stem cells responsible for myeloproliferative neoplasm-blast phase.
Wang, Xiaoli; Rampal, Raajit K; Hu, Cing Siang; Tripodi, Joseph; Farnoud, Noushin; Petersen, Bruce; Rossi, Michael R; Patel, Minal; McGovern, Erin; Najfeld, Vesna; Iancu-Rubin, Camelia; Lu, Min; Davis, Andrew; Kremyanskaya, Marina; Weinberg, Rona Singer; Mascarenhas, John; Hoffman, Ronald.
Afiliação
  • Wang X; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Rampal RK; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Hu CS; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Tripodi J; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Farnoud N; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Petersen B; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Rossi MR; Genetics and Genomic Sciences, ISMMS, New York, New York.
  • Patel M; Sema4, Stamford, Connecticut, USA.
  • McGovern E; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Najfeld V; Center for Hematologic Malignancies, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Iancu-Rubin C; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Lu M; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Davis A; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Kremyanskaya M; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Weinberg RS; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
  • Mascarenhas J; New York Blood Center, New York, New York, USA.
  • Hoffman R; Division of Hematology/Medical Oncology/Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai (ISMMS), New York, New York, USA.
JCI Insight ; 7(8)2022 04 22.
Article em En | MEDLINE | ID: mdl-35259128

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Crise Blástica / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Crise Blástica / Transtornos Mieloproliferativos Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article